Primary Site >> Colorectal Cancer
Gene >> RASA4
| 1. | |||||||||||
| Journal: | World J Gastroenterol. 2009 Jan 28;15(4):449-56. | ||||||||||
| Title: | Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients. | ||||||||||
| Author: | Moehler, Markus|Sprinzl, Martin-F|Abdelfattah, Murad|Schimanski, Carl-C|Adami, Bernd|Godderz, Werner|Majer, Klaus|Flieger, Dimitri|Teufel, Andreas|Siebler, Juergen|Hoehler, Thomas|Galle, Peter-R|Kanzler, Stephan | ||||||||||
| PMID: | 19152449 | ||||||||||
| 2. | |||||||||||
| Journal: | Ginekol Pol. 2014 Mar;85(3):172-9. | ||||||||||
| Title: | [Expression profile of genes associated with the histaminergic system estimated by oligonucleotide microarray analysis HG-U133A in women with endometrial adenocarcinoma]. | ||||||||||
| Author: | Jeda, Agnieszka|Witek, Andrzej|Janikowska, Grazyna|Cwynar, Grzegorz|Janikowski, Tomasz|Cialon, Malgorzata|Orchel, Joanna|Mazurek, Urszula | ||||||||||
| PMID: | 24783427 | ||||||||||
| 3. | |||||||||||
| Journal: | Ann Oncol. 2014 Sep;25(9):1756-61. | ||||||||||
| Title: | Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial. | ||||||||||
| Author: | Ciardiello, F|Normanno, N|Maiello, E|Martinelli, E|Troiani, T|Pisconti, S|Giuliani, F|Barone, C|Carteni, G|Rachiglio, A M|Montesarchio, V|Tonini, G|Rizzi, D|Cinieri, S|Bordonaro, R|Febbraro, A|De Vita, F|Orditura, M|Fenizia, F|Lambiase, M|Rinaldi, A|Tatan | ||||||||||
| PMID: | 24942275 | ||||||||||
| 4. | |||||||||||
| Journal: | Ann Oncol. 2015 Aug;26(8):1710-4. | ||||||||||
| Title: | Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial. | ||||||||||
| Author: | Normanno, N|Rachiglio, A M|Lambiase, M|Martinelli, E|Fenizia, F|Esposito, C|Roma, C|Troiani, T|Rizzi, D|Tatangelo, F|Botti, G|Maiello, E|Colucci, G|Ciardiello, F | ||||||||||
| PMID: | 25851630 | ||||||||||
| 5. | |||||||||||
| Journal: | Ann Oncol. 2016 Jun;27(6):1055-61. | ||||||||||
| Title: | Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX. | ||||||||||
| Author: | Ciardiello, F|Normanno, N|Martinelli, E|Troiani, T|Pisconti, S|Cardone, C|Nappi, A|Bordonaro, A R|Rachiglio, M|Lambiase, M|Latiano, T P|Modoni, G|Cordio, S|Giuliani, F|Biglietto, M|Montesarchio, V|Barone, C|Tonini, G|Cinieri, S|Febbraro, A|Rizzi, D|De Vit | ||||||||||
| PMID: | 27002107 | ||||||||||
| 6. | |||||||||||
| Journal: | Ann Oncol. 2018 Jan 1;29(1):112-118. | ||||||||||
| Title: | RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial. | ||||||||||
| Author: | Normanno, N|Esposito Abate, R|Lambiase, M|Forgione, L|Cardone, C|Iannaccone, A|Sacco, A|Rachiglio, A M|Martinelli, E|Rizzi, D|Pisconti, S|Biglietto, M|Bordonaro, R|Troiani, T|Latiano, T P|Giuliani, F|Leo, S|Rinaldi, A|Maiello, E|Ciardiello, F | ||||||||||
| PMID: | 28950295 | ||||||||||